THROMBELASTOGRAPH COAGULATION ANALYZER TEG-5000 SERIES— 510(k) K002177
Substantially EquivalentHaemoscope Corp.
FDA 510(k) clearance K002177 for THROMBELASTOGRAPH COAGULATION ANALYZER TEG-5000 SERIES, Substantially Equivalent on 2000-09-14. Applicant: Haemoscope Corp.. Device class: 2.
Clearance details
- Applicant
- Haemoscope Corp.
- Product code
- Code JPA
- Device class
- Class 2
- Regulation
- 21 CFR 864.5425
- Advisory panel
- Hematology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Skokie, IL, US
Recent devices under product code JPA
view allMore clearances from Haemoscope Corp.
view allAdverse events under product code JPA
product code JPA- Death
- 6
- Total
- 6
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K002177
K-number listed on FDA's recall record- Z-1310-2022 — TEG 5000 Functional Fibrinogen Reagent, Item No. 07-034
- Z-1298-2022 — Product Name: TEG5000 Analyzer (07-022, 07-033) with TEG Analytical Software (07-030, 07-031) and TEG Platelet Mapping Assay - PlateletMapping ADP & AA (07-014), PlateletMapping ADP (07-015), PlateletMapping AA (07-016). Issue occurs when Platelet Mapping Assay results from a TEG 5000 analyzer are viewed using TEG Manager Software (versions 1.1-4.3.1)
- Z-1617-2020 — TEG Manager software versions used in conjunction with TEG 5000 are 1.1.0, 3.0.0, 4.0.0, 4.1.0 and 4.1.1. Intended: For in vitro coagulation studies
- Z-1130-2015 — Haemonetics TEG Hemostasis System Level II Control, Catalog number: 8002. Level II Control is a biological control for use with the Thrombelastograph (TEG) Hemostasis System.
- Z-1796-2013 — TEG 5000 Thromboelastograph Coagulation Analyzer Product Usage: Multipurpose System for In Vitro Coagulation Studies
Matched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K002177.
Data sourced from openFDA. This site is unofficial and independent of the FDA.